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Purpose: An earlier adoption of contraceptive methods during the postpartum period could help 
women to extend the inter-pregnancy interval. This article aimed to determine and compare the 
timing of long-acting reversible contraceptives (LARC) use (ie, intrauterine device and implant) 
in Burkina Faso (BF) and DR Congo (DRC) between the intervention and control groups.
Patients and Methods: A total of 1120 postpartum women were enrolled and followed up 
to 12 months postpartum. We used Yam-Daabo trial data which was a multi-intervention, 
single-blinded, cluster-randomised controlled trial done in primary health-care centres (clus-
ters) in both countries. Centres were randomly allocated to receive the six-component 
intervention or standard antenatal and postnatal care in matched pairs (1:1). We did 
a secondary analysis using Royston-Parmar’s semi-parametric model to estimate the effect 
of the interventions on the median time of LARC uptake.
Results: Our analysis included 567 postpartum women in BF (284 in the intervention group 
and 283 in the control group) and 553 in the DRC (274 in the intervention group and 279 in 
the control group). After showing an increase in family planning use in these two African 
countries, Yam Daabo’s interventions showed a reduction of the median time of LARCs 
adoption in the intervention group compared to the control group in both countries (differ-
ence of 39 days in Burkina Faso; difference of 86 days in the DR Congo).
Conclusion: The Yam Daabo intervention package resulted in increased and earlier adop-
tion of LARC in rural settings in Burkina Faso and urban settings in DR Congo. Such an 
intervention could be relevant in similar contexts in Sub-Saharan Africa with very high 
fertility rates and high unmet needs for contraception.
Keywords: family planning, postpartum, long-acting reversible contraceptives, sub-Saharan 
Africa
Introduction
To prevent maternal deaths, family planning (FP) is an effective strategy to address 
women’s and couples’ fertility choices by helping them limit the number of 
children and extend the inter-pregnancy interval by at least two years.1 
According to an analysis of 27 countries Demographic and Health Surveys 
(DHS), 95% of women who gave birth within the previous 12 months wished to 
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avoid a pregnancy in the following 24 months, but up to 
70% did not use contraception.2 Several interventions to 
help women satisfy their contraceptive needs in the post-
partum period have been implemented in many countries. 
Research in different contexts, where interventions 
focused on counseling (during pregnancy and after child-
birth), showed a significant increase in the use of contra-
ceptive methods in the postpartum period.3,4 In contrast 
with single-intervention studies, Yam Daabo (which 
means “your choice” in Mooré, one of the local languages 
in Burkina Faso) was a cluster randomized-controlled trial 
that tested a set of different Postpartum family planning 
(PPFP) interventions implemented from the third trimester 
of pregnancy throughout the extended postpartum period 
until one year. Yam Daabo aimed at strengthening existing 
primary health-care services and did not focus on promot-
ing a specific contraceptive method.
The DRC and Burkina Faso are two sub-Saharan 
Africa countries, with a population of 86,791,000 in 
2019,5 for the DRC and 20,321,000 in 2019 for the BF.6 
According to the study by Ahmed et al,7 the modern 
contraceptive prevalence rate (mCPR) among all women 
in Burkina was 24.7% and, 10.0% in the DRC in 2017. 
The unmet needs for modern method were respectively 
27.2% and 39.9%. The demand satisfied with modern 
methods were respectively 47.6% and 20.0%. Similar to 
the majority of sub-Saharan African countries, cultural 
norms favor large families, with fertility rates higher in 
rural than urban areas. For instance, in 2019, Burkina Faso 
had 5.6 and the DRC 6.4 lives birth per woman.5,6
Yam Daabo was effective in increasing the use of 
modern PPFP methods at 12 months postpartum. In 
Burkina Faso, the modern contraceptive prevalence was 
55% among women who received the package and 29% 
among those who received routine care in control clusters 
(adjusted prevalence ratio 1.79, 95% CI=1.30−2.47).8 In 
DR Congo, the modern contraceptive prevalence was 46% 
among women in the intervention group and 35% in the 
control group (adjusted prevalence ratio 1.58, 95% 
CI=0.74−3.38).9 But, Yam Daabo interventions had no 
effect on modern methods discontinuation.10
All of the studies that measured the effects of various 
interventions on postpartum family planning (PPFP) 
uptake did not explore the median time to contraceptives 
adoption. In other words, we do not know whether pre-
vious interventions contribute to earlier adoption of meth-
ods among women in the intervention group than those in 
the control group.
This paper aims to explore the time to long-acting 
reversible contraceptives (LARC) uptake in both coun-
tries. We are looking at the effect of Yam Daabo interven-
tion on the time to long-acting reversible contraceptives by 
comparing this in intervention and control cohorts. We 
focused this analysis on LARC methods because they 
have specific advantages, including a high satisfaction 
rate and low discontinuation rate.11 Another reason for 
analyzing LARC uptake is that their use requires 
a skilled service provider who may not be available in 
certain outreach areas in low-income countries like 
Burkina Faso and DR Congo.12
Patients and Methods
We performed a secondary analysis of the Yam Daabo 
study, which was a two-group, multi-intervention, single- 
blinded, cluster-randomized controlled trial with health 
centres as the randomization units. The study involved 
two countries: Burkina Faso and the DR Congo.
Health centers were eligible if (1) they offer the con-
tinuum of antenatal care, delivery, and postnatal care; (2) 
they provide a selection of at least three modern contra-
ceptive methods, including a barrier method such as con-
dom, a short-term method such as pills, a long-term 
method such as intra-uterine device and referrals for per-
manent methods to clients; (3) there were no stock-outs of 
contraceptives during the preceding six months; (4) they 
have on average at least thirty deliveries per month; (5) 
they are situated within four hours drive from the research 
center; and (6) they are willing to participate. Thus, in 
each country, eight others were allocated randomly to the 
experimental and control groups of the intervention phase. 
So, we conducted the trial in eight primary health centers 
which were matched by pairs according to (1) the average 
number of deliveries per month, (2) the ratio of health 
workers per population, and (3) the settings (rural, urban). 
Within each of the four pairs, we randomly selected the 
site assigned to the experimental intervention. All pregnant 
women were eligible to participate in the study if (1) they 
were in their third pregnancy trimester; (2) the status of the 
pregnancy and the woman allowed for a birth at the health 
center; (3) the woman had the intention to attend ANC, 
delivery, and PNC at the health center; (4) the woman did 
not participate in another study; and (5) we obtained 
informed consent. Research assistants collected data on 
paper-based Case Report Forms (CRF). The world health 
organization (WHO) team in Geneva developed the CRF 
with inputs from the country research teams. Each health 
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center had a research assistant who was trained to adhere 
to the study manual and standard operating procedures for 
data management, which are common to both study coun-
tries and have been developed by WHO. The information 
reported on the CRFs was checked for accuracy and com-
pleteness several times at different levels by field coordi-
nators and data managers. The Biostatistics and Data 
Management team developed the electronic CRF (eCRF) 
through OpenClinica (version 3.11), an electronic data 
capture software for clinical research, which includes pro-
grammed edit checks for data accuracy, completeness, and 
consistency, reduces delays in data queries and problem 
resolution. Further methodological details on the Yam 
Daabo trial are available elsewhere.13
Study Period
We have included pregnant women from July 27 to 
October 17, 2016. We followed all the pregnant women 
up to twelve months after delivery. So, the last follow-up 
date was February 28, 2018.
Interventions
The package comprised three facility-based interventions 
(PPFP refresher course for providers, supportive supervi-
sion, and availability of contraceptive services seven days 
a week) and three client-oriented interventions (invitation 
letter to husbands or partners, appointment card, and 
a decision-making tool for clients and providers to enable 
a systematic counseling approach on PPFP).
The health centers of the experimental group implemen-
ted the PPFP intervention package. The control group 
implemented the usual care. Depending on the final 
package’s nature, some were implemented before participant 
recruitment (such as PPFP refresher training for service 
providers). In contrast, others were implemented afterward 
(such as using the PPFP counseling tool with participants). 
Participants received individual-based interventions during 
third-trimester antenatal care visits and postnatal care fol-
low-up visits, according to national practice (typically on 
clinical discharge [24−48 h], at 6 days, 6 weeks, then at 
months 6 and 9, before the trial exit at month 12 postpar-
tum). In many African countries, the routine Postpartum 
care (PPC) is offered to women at different times, based 
on WHO recommendations. The WHO guidelines for 
maternal and infant Postpartum care (PPC) include guidance 
on routine care, such as monitoring the wellbeing of the 
mother and/or baby, early detection and management of 
complications, preventive measures and counseling, and 
family planning. The recommended timing, including the 
number of postpartum contacts for all mothers and new-
borns, evolved from the renowned formula of “6 hours, 6 
days, 6 weeks and 6 months” after birth to four postpartum 
visits: on the first day, at day 3 (48–72 h), between days 
7–14, and 6 weeks after birth.14
Outcomes
In this analysis, we focused on LARC methods 
(Intrauterine devices and implants). We did not consider 
the short-acting methods (pills, injectables, condoms, sper-
micides, and the lactational amenorrhea method). We per-
formed an intention-to-treat analysis, and our event of 
interest was the LARC uptake.
Statistical Analysis
Considering the choice of our outcome and the data’s nature, 
we opted for survival analysis. Since we performed 
a survival analysis, we focused on the distribution of the 
aleatory variable, elapsed time from delivery until the adop-
tion of a LARC, continuously positive, noted as T among the 
study’s women. A woman is called “right-censured” when 
she is still at risk of adopting a LARC at twelve months 
postpartum. In our study, all the participants are “left- 
truncated” because a woman can adopt a LARC only after 
delivery, meaning that before delivery, the woman cannot 
adopt a LARC. There is a date of origin for each woman, 
which is the date of delivery, and thus, the beginning of the 
follow-up, and an end date of the follow-up (12 months 
postpartum). If the participant adopted of LARC during the 
follow-up, this end-of-observation date corresponds to the 
date of LARC use. If the participant did not adopt a LARC 
during the follow-up, the end date corresponds to the study’s 
end date (ie, 12 months postpartum). For women lost to 
follow-up, the end date is the date of the last interview 
conducted. Thus, we obtain a duration until LARC use for 
each participant or until the end of the observation period, 
which will allow us to estimate the probability of LARC use.
For the selection of the type of modeling, we com-
pared the different models (Kaplan-Meier non- 
parametric modeling, parametric modeling (Weibull, 
Exponential, Gompertz, Loglogistic, Lognormal, 
G-gamma and Royston–Parmar), and semi-parametric 
modeling (Cox’s modeling)) using the Akaike’s 
Information Criteria (AIC). The Royston-Parmar’s flex-
ible model had the lowest AIC and was therefore 
selected.
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We used the Stata stpm2 command15 to estimate the 
intervention effect on LARC use. This command fits 
flexible parametric regression models (Royston–Parmar 
models using restricted cubic splines functions) by 
directly modeling the cumulative incidence function 
(CIF). The command also produces estimates of hazard 
ratios (HR) for our exposure variable. We adjusted the 
results for all the variables found to be imbalanced 
between the intervention and control group. To be con-
sistent with comparing the adjusted hazard ratios between 
the two countries, we calculated stratified rate ratios and 
significance tests by using a Mantel-Haenszel-type 
method. We also produced the CIF curves for LARC 
uptake over time in each country and computed the med-
ian survival time and restricted mean survival time of 
adopting a LARC.
Ethics Approval
The trial was approved by the WHO Research Ethics 
Review Committee, the ethics committee for health 
research in Burkina Faso, and the School of Public 
Health ethics committee in DR Congo. Moreover, the 
trial was registered in the Pan African Clinical Trials 
Registry (PACTR201609001784334) and was conducted 
in accordance with the Declaration of Helsinki.
Results
Our analysis included 567 postpartum women in Burkina 
Faso (284 in the intervention group) and 553 in DR Congo 
(274 in the intervention group). Figure 1 section sum-
marizes the study flow.
The baseline comparison between the control and the 
intervention group showed with Burkina Faso’s data 
a significant difference for the woman’s age (p=0.021), the 
number of pregnancies (p=0.048) and the number of abortion 
(p=0.007). The DRC data comparison showed a significant 
difference for the number of stillbirths (p=0.017), the educa-
tion status (p=0.008) and the woman’s occupation (p=0.000). 
All these results are expressed in Table 1.
Effect of the Interventions on LARC 
Adoption
The adjusted results showed a positive effect of the interven-
tions on LARC adoption in Burkina Faso (Table 2): at 12 
months postpartum, when compared to the control group, 
women in the intervention group were 2.11 times more likely 
to use LARC (95% CI=1.48–3.02; p<0.001). In the DR Congo, 
1304 women screened
Burkina Faso: 614 women screened DR Congo: 690 women screened
26 non-eligible 56 non-eligible
286 enrolled 285 enrolled women
312 women in 
intervention group
302 women in 
control group
342 women in 
intervention group









86 women (out of 284) 





49 women (out of 283) used 
LARC at 12 months 
postpartum
58 women (out of 274) used 
LARC at 12 months 
postpartum
23 women (out of 279) used 








Figure 1 Flowchart of the study. 
Abbreviation: LARC, long-acting and reversible contraceptives.
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Table 1 Baseline Characteristics of Women at Inclusion After Delivery










n (%) n (%) n (%) n (%)
Women age 0.021 0.244
Under 20 39 (13.7) 59 (20.8) 29 (10.6) 22 (7.9)
20–29 145 (51.1) 149 (52.7) 134 (48.9) 155 (55.6)
≥30 100 (35.2) 75 (26.5) 111 (40.5) 102 (36.6)
Number of pregnancies 0.048 0.148
None 45 (15.8) 57 (20.1) 51 (18.6) 59 (21.1)
1–3 123 (43.3) 142 (50.2) 142 (51.8) 161 (57.7)
4–6 95 (33.5) 69 (24.4) 71 (25.9) 53 (19.0)
≥ 7 21 (7.4) 15 (5.3) 10 (3.6) 6 (2.2)
Number of living children 0.110 0.905
None 52 (18.3) 65 (23.0) 74 (27.0) 76 (27.2)
1–3 143 (50.4) 150 (53.0) 155 (56.6) 161 (57.7)
≥ 4 89 (31.3) 68 (24.0) 45 (16.4) 42 (15.1)
Number of previous live births 0.095 0.693
None 51 (18.0) 61 (21.6) 74 (27.0) 74 (26.5)
1–3 131 (46.1) 144 (50.9) 151 (55.1) 162 (58.1)
≥4 102 (35.9) 78 (27.6) 49 (17.9) 43 (15.4)
Number of stillbirths 0.128 0.017
None 265 (93.3) 254 (89.8) 244 (89.1) 264 (94.6)
≥ 1 stillbirth 19 (6.7) 29 (10.2) 30 (10.9) 15 (5.4)
Number of abortion 0.007 0.082
None 247 (87.0) 265 (93.6) 203 (74.1) 224 (80.3)
≥ 1 abortion 37 (13.0) 18 (6.4) 71 (25.9) 55 (19.7)
Education status 0.943 0.008
No education 202 (71.1) 204 (72.1) 7 (2.6) 5 (1.8)
Primary school 39 (13.7) 39 (13.8) 36 (13.1) 65 (23.3)
Secondary/Tertiary 43 (15.1) 40 (14.1) 231 (84.3) 209 (74.9)
Marital status 0.733 0.400
Not in union 4 (1.4) 5 (1.8) 21 (7.7) 27 (9.7)
In union 280 (98.6) 278 (98.2) 253 (92.3) 252 (90.3)
(Continued)
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women of the intervention group were 3.5 times more likely to 
use LARC (HR=3.48; 95% CI=2.08–5.84; p<0.001) when 
compared to the control group women. However, there was 
no difference between the two countries’ adjusted rate ratio 
(p=0.344), meaning no difference between comparison of 
Burkina Faso and the DRC results.
Effect of the Interventions on the Median 
Time of Contraceptive Methods Adoption
Analysis of the median survival time and the restricted mean 
survival time of contraceptive methods adoption showed 
differences between the intervention and control groups in 
both countries (Table 3). In Burkina Faso, for the median 
Table 1 (Continued). 










n (%) n (%) n (%) n (%)
Occupation 0.605 0.000
No occupation 1 (0.4) 0 (0.0) 21 (7.7) 81 (29.0)
Student 25 (8.8) 21 (7.4) 11 (4.0) 12 (4.3)
Housewife/Farmer 228 (80.3) 231 (81.6) 185 (67.5) 108 (38.7)
Salaried employee 2 (0.7) 5 (1.8) 18 (6.6) 29 (10.4)
Tradeswoman 28 (9.9) 26 (9.2) 39 (14.2) 49 (17.6)
Family planning use prior to the 
trial
0.727 0.421
No 203 (71.5) 206 (72.8) 139 (50.7) 132 (47.3)
Yes 81 (28.5) 77 (27.2) 135 (49.3) 147 (52.7)
Current pregnancy planned 0.100 0.431
Yes 143 (50.4) 123 (43.5) 186 (67.9) 198 (71.0)
No 141 (49.6) 160 (56.5) 88 (32.1) 81 (29.0)
Table 2 Use of Long-Acting and Reversible Contraceptives at 12 Months Postpartum
Crude Hazard Ratio (95% CI) p Adjusted Hazard Ratio (95% CI) p
Burkina Faso
Control group
Intervention group 2.27 (1.60–3.23) <0.001 2.11 (1.48–3.02)† <0.001
DR Congo
Control group
Intervention group 2.94 (1.81–4.76) <0.001 3.48 (2.08–5.84)‡ <0.001
Pooled data
Control group
Intervention group 2.44 (1.84–3.24) <0.001 2.49 (1.86–3.34)* <0.001
Notes: Covariables: †For Burkina: age, pregnancy number, and abortion number. ‡For the DRC: stillbirth number, educational status, and occupation. *For the pooled data: 
age, pregnancy number, abortion number, stillbirth number, educational status, and occupation.
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survival time, there was on average a difference of 39 days 
(5 weeks and 4 days) for time to LARC uptake, as users in 
the intervention group adopted their method at 55 days 
postpartum (just under 2 months) against 94 days (more 
than 3 months) in the control group. In DR Congo, the 
difference was 86 days (close to 3 months), with a median 
time to LARC uptake at 75 days postpartum (2.5 months) in 
the intervention group versus 161 days (approximately 5 
months and 15 days) in the control group.
Analysis of the restricted mean survival time of LARC 
adoption showed similar differences. These differences are 
also expressed in Figure 2. On this figure, we noted that 
the cumulative incidence curve of the Burkina comparison 
group has a similar evolution over the time to that of the 
intervention group in DR Congo.
Discussion
Findings and Interpretations
First, although Yam Daabo did not promote a particular 
method, our results showed that Yam Daabo interventions 
had similar effects on significantly increasing LARC adop-
tion in Burkina Faso and DR Congo as compared intensity 
testing between the two countries did not find a significant 
difference. It is important to note that the majority of 
Figure 2 Cumulative incidence of long-acting reversible contraceptives adoption.
Table 3 Proportion of Long-Acting and Reversible Contraceptives Users and Median Survival Time and Restricted 
Mean Survival Time (RMST) of Adoption
Number of Users/Total Number of Women Median Time RMST
Burkina Faso
Control group 49/283 94 106 (85–128)
Intervention group 86/284 55 98 (78–117)
DR Congo
Control group 23/279 161 192 (149–235)
Intervention group 58/274 75 113 (84–141)
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LARC services concerned implants, as service providers at 
the primary health-care clinics enrolled in Yam Daabo, 
were mostly auxiliary midwives or nurses who were not 
allowed to offer IUDs, unlike midwives or physicians. 
LARC methods provide security against pregnancy and 
are simple to use (no daily or periodic administration) 
and cost-effective in the long term. According to Secura, 
in 2013, the use of LARC is more than 99% effective 
against pregnancies and over 20 times more effective at 
preventing unintended pregnancy compared to the contra-
ceptive pill, patch, or ring.16 The effect of Yam Daabo on 
LARC uptake maybe because its interventions addressed 
several service utilization barriers like the low knowledge 
and skills of service providers, misconceptions among 
providers and clients. Providers’ adequate knowledge and 
skills, which were strengthened by supportive supervision, 
combined with quality counseling over several encounters, 
were likely contributing factors.
Second, our results showed an earlier adoption of LARC 
in the intervention groups of both countries. On average, the 
control groups, which received routine care, adopted LARC 
later than the 6-week postpartum visit, which is dedicated in 
both countries to PPFP information and services. In Burkina 
Faso, it was at 3 months postpartum for LARC, which con-
trasted with a much later adoption in the DRC at more than 5 
months postpartum for LARC. Our Yam Daabo formative 
research already revealed that women appeared to rarely 
attend the 6-week postpartum visit,17 which is confirmed by 
this secondary analysis. Nonetheless, for similar contexts in 
Sub-Saharan Africa, our interventions could help improve an 
earlier and increased adoption of postpartum contraceptives, 
which could help women effectively extend their inter- 
pregnancy interval or limit the number of children. So, 
regarding the advantages of LARC, further research must 
focus on reducing the time to LARC uptake, especially in 
postpartum women. The decision-makers and health provi-
ders should support women in attending the six-week visit 
and ensuring that they can adopt a LARC early (no stock- 
outs, availability of skilled providers).
Third, as noted above, there was an earlier adoption of 
LARC in Burkina Faso than in the DRC. In addition to the 
difference in research settings (rural vs urban), various factors 
could further explain the contrasting results, including the 
heterogeneity between both countries in terms of perinatal 
policies and systems; varying levels of facility-based delivery; 
differences in maternity care providers; heterogeneous quality 
of care; and other determinants pertaining to contexts, values, 
and experiences of postpartum care. Yam Daabo interventions 
aimed to strengthen some of these factors within an overall 
primary health-care service strengthening approach, which 
was aligned with national health policies.13 While 91% of the 
766 health facilities in Burkina Faso surveyed in the Service 
Availability and Readiness Assessment (SARA) survey 
offered at least one method in 2014, only 33% of the 1555 
health facilities surveyed in the DRC provided at least one 
method in 2014. When comparing the proportion of health 
facilities offering implants, it was 80% in BF in 2014 compared 
to 11% in DRC in the same year.18 Comparison of the propor-
tions of health facilities that experienced contraceptive stock- 
outs also shows enormous disparities. Moreover, besides, to 
support the idea of structural differences between the health 
systems and policies of both countries, an analysis of the DHS 
data in Burkina (2010) and the DR Congo (2013), showed 
differences between the proportions of women who attended 
postpartum visits at six weeks. In Burkina Faso, 72% of post-
partum women received postnatal care within 48 hours of 
childbirth against 44% in DR Congo. Moreover, 52% of 
women did not receive postnatal care (including late care, ie, 
41 days after delivery) in DR Congo19 against 17% in Burkina 
Faso.20 However, during this period, counseling may be critical 
to equip women with knowledge to inform the adoption of 
contraceptive methods of their choice. Thus, if women do not 
return to health centers, they will not be adequately exposed to 
PPFP information and services. Also, according to Kwete et al, 
several factors could explain the high reliance on traditional 
methods in DR Congo, which would delay their adoption of 
modern contraceptives: the years of political turmoil that led to 
a scarcity of medical supplies, the deeply ingrained fear of side 
effects (particularly the sterility) from modern methods, and 
the promotion of natural methods by faith-based organizations 
that run more than half of the health facilities in the country.21 
All the factors mentioned above could have had an effect on 
time to LARC uptake.
Limitations
In the present study, we focused on the timing of LARC 
uptake among postpartum women. The limitations described 
in the main papers are also valid for this secondary analysis. It 
is essential to mention that three out of four control sites in the 
DRC have been contaminated during the trial by implement-
ing other family planning interventions. In these three control 
sites, despite not focusing on postpartum family planning, 
these interventions were linked to HIV or family planning 
programming and were also offered to women postpartum, 
including to Yam Daabo participants. These interventions 
delivered free family planning services in one center, 
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including long-acting and reversible contraceptives, provid-
ing free contraceptive methods and services in the other 
center. In the last center, the intervention was free condom 
distribution and other family planning methods and services. 
During these interventions, the implant was free, but its 
insertion services were not. So, in the DRC, the Yam Daabo 
intervention package was not compared with typical routine 
care, but with other family-planning-related activities. 
However, our postpartum family planning-focused interven-
tion, compared with other family-planning-related activities 
in control sites, proved more effective in enabling women to 
adopt a LARC.
Our study had no data on husband approval of contra-
ceptive initiation and resumption of sexual activity. 
Several authors have found these variables to influence 
postpartum use of a modern contraceptive method.22,23 
Therefore, the time of a LARC initiation is also influenced 
by these variables.
Conclusion
Yam Daabo’s interventions showed a reduction of the 
median time of LARCs adoption in the intervention 
group compared to the control group in two African coun-
tries with different contexts. These results have critical 
programmatic implications for countries with very high 
fertility rates with high unmet needs for contraception.
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